These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22535331)

  • 41. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
    Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
    Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration.
    Ladas ID; Chatziralli IP; Kotsolis AI; Douvali M; Georgalas I; Theodossiadis PG; Rouvas AA
    Ophthalmologica; 2012; 228(2):93-101. PubMed ID: 22571933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of fixation in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab.
    Mathew R; Pearce E; Sivaprasad S
    Am J Ophthalmol; 2012 Mar; 153(3):490-496.e1. PubMed ID: 22071230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting.
    Gomi F; Migita H; Sakaguchi T; Okada H; Sugawara T; Hikichi Y;
    Jpn J Ophthalmol; 2019 Nov; 63(6):437-447. PubMed ID: 31673841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visual functioning and quality of life under low luminance: evaluation of the German Low Luminance Questionnaire.
    Finger RP; Fenwick E; Owsley C; Holz FG; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8241-9. PubMed ID: 21908584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of repeated intravitreal bevacizumab injections on the inner retinal function in neovascular age-related macular degeneration.
    Kim HD; Kim SH; Cho IH; Moon CH; Ohn YH; Park TK
    Acta Ophthalmol; 2013 Mar; 91(2):e154-6. PubMed ID: 22989051
    [No Abstract]   [Full Text] [Related]  

  • 48. Feasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot study.
    Kaiser PK; Wang YZ; He YG; Weisberger A; Wolf S; Smith CH
    Retina; 2013 Oct; 33(9):1863-70. PubMed ID: 23609122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Disease perception in patients with wet age-related macular degeneration].
    Kostadinov F; Valmaggia C
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):525-8. PubMed ID: 25902113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population.
    Jelin E; Wisløff T; Moe MC; Heiberg T
    Health Qual Life Outcomes; 2019 Aug; 17(1):140. PubMed ID: 31412873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study.
    Bertelmann T; Feltgen N; Scheffler M; Hufenbach U; Wiedon A; Wilhelm H; Ziemssen F
    Health Qual Life Outcomes; 2016 Sep; 14(1):132. PubMed ID: 27644469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of the severity of vision loss on vision-related quality of life in India: an evaluation of the IND-VFQ-33.
    Finger RP; Kupitz DG; Holz FG; Balasubramaniam B; Ramani RV; Lamoureux EL; Fenwick E
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6081-8. PubMed ID: 21693607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice.
    Wang LL; Liu WJ; Liu HY; Xu X
    Chin Med J (Engl); 2015 May; 128(9):1154-9. PubMed ID: 25947396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
    Brazier J; Muston D; Konwea H; Power GS; Barzey V; Lloyd A; Sowade O; Vitti B; Gerlinger C; Roberts J
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4818-4825. PubMed ID: 28973328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychological impact of anti-VEGF treatments for wet macular degeneration-a review.
    Senra H; Ali Z; Balaskas K; Aslam T
    Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1873-1880. PubMed ID: 27262729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review.
    Lanzetta P; Mitchell P; Wolf S; Veritti D
    Br J Ophthalmol; 2013 Dec; 97(12):1497-507. PubMed ID: 23929309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utility and uncorrected refractive error.
    Tahhan N; Papas E; Fricke TR; Frick KD; Holden BA
    Ophthalmology; 2013 Sep; 120(9):1736-44. PubMed ID: 23664469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment satisfaction of patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents.
    Marakis TP; Koutsandrea C; Chatzistefanou KI; Tountas Y
    Int Ophthalmol; 2018 Apr; 38(2):565-576. PubMed ID: 28285389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of keratoconus in the better eye and the worse eye on vision-related quality of life.
    Sahebjada S; Fenwick EK; Xie J; Snibson GR; Daniell MD; Baird PN
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):412-6. PubMed ID: 24398095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.